Review the methotrexate bone marrow suppression trend. | MyMerci
More questions like thisTry ›
Medication Administration

Review the methotrexate bone marrow suppression trend.

Trend

Choose your responses, then check the answer.

TimeData
BaselineMethotrexate started for rheumatoid arthritis; WBC 6,800/mm3
Month 2Mouth ulcers, fatigue, WBC 2,400/mm3, platelets 92,000/mm3
Clinic callTemperature 38.5 C, sore throat, reports taking extra weekly doses by mistake

Q1. What is the priority concern?

Q2. Which action should the nurse take?

Explanation
Mouth ulcers, cytopenias, fever, sore throat, and dosing error suggest methotrexate toxicity and severe infection risk. Urgent evaluation and provider notification are required.
Next question on this topicBefore giving a scheduled dose of digoxin, the nurse obtains an apical pulse of 54/min in …From this question bank[전통+신유형] NCLEX LEVEL UP 패키지KRW 79,000
Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free

For study reference only. Always follow current clinical guidelines and your institution’s protocols.